Inventor · disambiguated record
Michael R. Hanley
Also filed as: HANLEY MICHAEL · HANLEY MICHAEL R
20 granted patents·8 pending applications·275 citations·filing 2000–2019
95Inventor score
Files withLEVY ODILE ESTHER6AMYLIN PHARMACEUTICALS INC4CHEMOCENTRYX INC4AMYLIN PHARMACEUTICALS LLC3LAUGERO KEVIN D3
Top patents by PatentIndex Score
28 records- 0197US8076288B2Hybrid polypeptides having glucose lowering activityLEVY ODILE ESTHER·Filed 2005·Granted Dec 13, 2011·49 cites·7 claims
- 0296US8263545B2GIP analog and hybrid polypeptides with selectable propertiesLEVY ODILE ESTHER·Filed 2007·Granted Sep 11, 2012·62 cites·3 claims
- 0395US8697647B2Hybrid polypeptides with selectable propertiesLEVY ODILE ESTHER·Filed 2011·Granted Apr 15, 2014·15 cites·20 claims
- 0495US8497240B2DPP-IV resistant GIP hybrid polypeptides with selectable propertiesLEVY ODILE ESTHER·Filed 2007·Granted Jul 30, 2013·25 cites·11 claims
- 0593US8114958B2Amylin family peptidesSOARES CHRISTOPHER J·Filed 2005·Granted Feb 14, 2012·24 cites·10 claims
- 0690US8598120B2Methods for treatment using amylin family peptidesSOARES CHRISTOPHER J·Filed 2012·Granted Dec 3, 2013·14 cites·8 claims
- 0790US8404637B2GIP analog and hybrid polypeptides with selectable propertiesLEVY ODILE ESTHER·Filed 2006·Granted Mar 26, 2013·16 cites·12 claims
- 0889US7671023B2Amylin agonist for treating depression, anxiety disorder and schizophreniaAMYLIN PHARMACEUTICALS INC·Filed 2006·Granted Mar 2, 2010·8 cites·3 claims
- 0986US7378444B2Analogues of lipid mediators derived from omega-3 PUFAs and methods of useBRIGHAM & WOMENS HOSPITAL·Filed 2003·Granted May 27, 2008·26 cites·9 claims
- 1086US6998239B1Method for identifying a modulator of the binding of CCX CKR polypeptide to a chemokineCHEMOCENTRYX INC·Filed 2000·Granted Feb 14, 2006·12 cites·17 claims
- 1183US7595341B2Analogues of lipid mediators derived from ω-3 PUFAs and methods of useRESOLVYX PHARMACUTICALS INC·Filed 2008·Granted Sep 29, 2009·11 cites·7 claims
- 1276US8389477B2Amylin and amylin agonists for treating psychiatric diseases and disordersLAUGERO KEVIN D·Filed 2011·Granted Mar 5, 2013·2 cites·14 claims
- 1373US8309522B2Neuromedin and FN-38 peptides for treating psychiatric diseasesLAUGERO KEVIN D·Filed 2008·Granted Nov 13, 2012·3 cites·4 claims
- 1470US9133260B2GIP analog and hybrid polypeptides with selectable propertiesAMYLIN PHARMACEUTICALS LLC·Filed 2013·Granted Sep 15, 2015·1 cites·8 claims
- 1570US2010125054A1Amylin and Amylin Agonists for Treating Psychiatric Diseases and DisordersAMYLIN PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 1669US6835547B1Methods for identifying modulators of CCX CKR activityCHEMOCENTRYX INC·Filed 2000·Granted Dec 28, 2004·7 cites·34 claims
- 1766US9453063B2Hybrid polypeptides with selectable propertiesAMYLIN PHARMACEUTICALS LLC·Filed 2014·Granted Sep 27, 2016·0 cites·12 claims
- 1861US7108990B2Chemokine receptorCHEMOCENTRYX INC·Filed 2004·Granted Sep 19, 2006·0 cites·14 claims
- 1959US2013184213A1Amylin and Amylin Agonists for Treating Psychiatric Diseases and DisordersLAUGERO KEVIN D·Filed 2013·Application pending·0 cites
- 2055US8895498B2GIP and exendin hybrid polypeptidesLEVY ODILE ESTHER·Filed 2012·Granted Nov 25, 2014·0 cites·6 claims
- 2155US2009181890A1Amylin and Amylin Agonists for Treating Psychiatric Diseases and DisordersAMYLIN PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 2251US11529363B2Methods of treating cancer in pediatric patientsARIAD PHARMA INC·Filed 2019·Granted Dec 20, 2022·0 cites·36 claims
- 2348US2013281374A1Dpp-iv resistant gip hybrid polypeptides with selectable propertiesASTRAZENECA PHARMACEUTICALS LP·Filed 2013·Application pending·0 cites
- 2446USRE39849EMethods for identifying modulators of CCX CKR activityCHEMOCENTRYX INC·Filed 2005·Granted Sep 18, 2007·0 cites·34 claims
- 2545US2013035294A1Neuromedin and FN-38 Peptides for Psychotic DiseasesAMYLIN PHARMACEUTICALS LLC·Filed 2012·Application pending·0 cites
- 2644US2009286723A1Hybrid Polypeptides with Selectable PropertiesAMYLIN PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 2741US2006094652A1Hybrid polypeptides with selectable propertiesLEVY ODILE E·Filed 2005·Application pending·0 cites
- 2839US2021047427A1Subcutaneous dosing of anti-cd38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael R. Hanley files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →